Grupo Espanol de trasplantes hematopoyeticos y terapia celular   Report issue

Academic/Hospital Phase 2
Founded: Madrid Spain (1994)

Organization Overview

First Clinical Trial
2010
NCT01956903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 2)

Graft vs Host Disease (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4